Icon

Qvar - (0.04,0.08 mg/INH; Aerosol, metered, Inhalation)

Beclomethasone Dipropionate Teva
0.04,0.08 mg/INH; Aerosol, metered, Inhalation
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
None None
QVAR is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older
Yes
***** ** ***. ***** ***** * **** ** ** ******* '***, '***, '***, '***, '***, '*** *** *** *********. ** ****** **** **** *** ****** ** *** ****. *****, ********* ***** * **** ** *** *** *********. ** ****** **** **** ********* ****** ** *** ****. ********* ** ****'* *** ******, ***** ******** **** ***** ** ****. ***** ** **** *** ** **** ** ** ***** *** *********, *** ******* ** *** ***** ******* ****** *******. ** ****** **** ***** * **** *** *** **** **** *** *********.
Qvar Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
***** **** ** ** **** ** ** ********* ********* ********* **** ** ** *** ** **
********* ******* ******* ********* ** ****** ** ********* ********* ** ****** ** ********* ******* ******* *** ** **
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** *, **** ********* **** ** ** / ******* **** ***** *** **, ****
********* ** \ ** *** **, **** ********* *** ** **/ ******* **** ** ** ****
  1. *** **, **** : ***** ******** **** ***** **'* **** ** ****** ** ******* '***, '***, '***, '***, '*** *** '***.
  2. *** *, **** : **** ***** * **** ******* ***** ** ******* '***, '***, '***, '***, '*** *** '***.
  3. *** *, **** : ********* ******** **** ***** **'* **** ** ****** ** ******* '***, '***, '***, '***, '*** '*** *** '***
  4. *** **, **** : **** ***** * **** ******* ********* ** *******, '***, '***, '***, '***, '*** '*** *** '***
  5. *** **, **** : **** *** ****** (************) ***** * **** ******* ***** ** ****** **. ***
  6. *** *, **** : **** ********* ****** ********* ******* '*** *** '*** ******* *****.
  7. *** **, **** : **** ********* ****** ********* ****** '*** ** ****** ** *****.
  8. *** *, **** : **** *** ********* ***** **** ****** '*** ** *** ********* ** *********.
  9. *** *, **** : **** *** ***** ***** **** ****** '*** ** *** ********* ** *****..
  10. *** **, **** : **** ********* ****** ********* ******* '*** *** '*** ** ****** ** *********.
  11. *** **, **** : **** ********* ****** ********* ****** '*** ******* *****.
  12. *** *, **** : **** *** ********* ******* ********** ** ********* *******.
  13. *** **, **** : ***** **** ** ** **** ******* '***, '***, *** '*** ** *** ** ***** ***** ******* ** ** ***** *** ********* ** *****. ***** ******** ** *** **.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.